Ketoprofen intravenous

Drug Profile

Ketoprofen intravenous

Alternative Names: NSAID analgesic - TheraQuest Biosciences; TQ-1011

Latest Information Update: 28 Jun 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator TheraQuest Biosciences LLC
  • Developer TheraQuest Biosciences
  • Class Analgesics; Antirheumatics; Nonsteroidal anti-inflammatories; Phenylpropionates; Small molecules
  • Mechanism of Action Lipoxygenase-cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Postoperative pain

Most Recent Events

  • 24 Jun 2010 Discontinued - Phase-II for Postoperative pain in USA (IV)
  • 18 Dec 2007 Phase-II development is ongoing
  • 30 Mar 2005 Clinical data from a media release have been added to the Pain pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top